Tumor‐Node‐Metastasis Staging of Pancreatic Adenocarcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Ca

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3322/CA.2007.0012PMID 18272835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

  2008cited by this paper
• Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.

  2007cited by this paper
• Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

  2007cited by this paper
• Validation of the 6th edition AJCC pancreatic cancer staging system

  2007cited by this paper
• Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

  2006cited by this paper
• Ultrasound-Guided Fine-Needle Aspiration Cytology

  2006cited by this paper
• Redefining the R1 resection in pancreatic cancer

  2006cited by this paper
• Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection

  2006cited by this paper
• [Analysis of a series of 100 mesenterico-portal vein resections during pancreatic resection].

  2006cited by this paper
• Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

  2006cited by this paper
• 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

  2006cited by this paper
• Pancreaticoduodenectomy in the presence of superior mesenteric venous obstruction

  2005cited by this paper
• Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer

  2005cited by this paper
• Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors

  2005cited by this paper
• Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.

  2004cited by this paper
• The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

  2004cited by this paper
• Confusion by Frequent Changes in Staging of Exocrine Pancreatic Carcinoma

  2004cited by this paper
• A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

  2004cited by this paper
• Endoscopic Ultrasound-Guided Fine Needle Aspiration is Superior to Lymph Node Echofeatures: A Prospective Evaluation of Mediastinal and Peri-Intestinal Lymphadenopathy

  2004cited by this paper
• Pancreaticoduodenectomy with vascular resection: margin status and survival duration

  2004cited by this paper
• Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head

  2003cited by this paper
• Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients

  2003cited by this paper
• Prognostic factors in the palliation of pancreatic cancer.

  2003cited by this paper
• Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.

  2003cited by this paper
• Clinicopathologic Evaluation After Resection for Ductal Adenocarcinoma of the Pancreas: A Retrospective, Single-Institution Experience

  2003cited by this paper
• Neoplasms of the Exocrine Pancreas

  2003cited by this paper
• Adenocarcinoma of the pancreas: CT imaging.

  2002cited by this paper
• Benefit of venous resection for ductal adenocarcinoma of the pancreatic head.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.

  2002cited by this paper
• Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.

  2001cited by this paper
• Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

  2001cited by this paper
• Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy

  2001cited by this paper
• Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

  2001cited by this paper
• Prognostic factors of long-term survival after resective procedures for pancreatic cancer.

  2001cited by this paper
• Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?

  2001cited by this paper
• Prognostic factors in the operative treatment of ductal pancreatic carcinoma

  2000cited by this paper
• Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas

  2000cited by this paper
• Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study

  2000cited by this paper
• Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators

  2000cited by this paper
• Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy

  2000cited by this paper
• Prognosis Factors in Carcinoma of the Head of the Pancreas

  2000cited by this paper
• Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P study group.

  2000cited by this paper
• Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

  1999influential reference
• Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis

  1999cited by this paper
• Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

  1999cited by this paper
• Prognostic Factors Associated with Resectable Adenocarcinoma of the Head of the Pancreas

  1999cited by this paper
• Pancreatic cancer: value of dual-phase helical CT in assessing resectability.

  1998cited by this paper
• Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

  1997cited by this paper
• Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.

  1997cited by this paper
• External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.

  1997cited by this paper
• Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

  1996influential reference
• Survival after resection for ductal adenocarcinoma of the pancreas

  1996cited by this paper
• Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.

  1996cited by this paper
• Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection?

  1996cited by this paper
• Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?

  1995cited by this paper
• Carcinoma of the periampullary region: who benefits from portal vein resection?

  1995cited by this paper
• Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

  1995cited by this paper
• Combined resection of the pancreas and portal vein for pancreatic cancer

  1994cited by this paper
• Perineural invasion of carcinoma of the pancreas and biliary tract

  1993cited by this paper
• Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

  1993cited by this paper
• Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

  1993cited by this paper
• Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

  1991cited by this paper
• Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus

  1991cited by this paper
• Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer

  1991influential reference
• Survival After Pancreatoduodenectomy: 118 Consecutive Resections Without an Operative Mortality

  1990cited by this paper
• Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas.

  1989cited by this paper
• Collective review of small carcinomas of the pancreas.

  1986cited by this paper
• Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

  1985cited by this paper
• Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

  1985influential reference
• [Cancer of the pancreas].

  1965cited by this paper

• Biological Characterization of One Oxadiazole Derivative (5(4‐Hydroxyphenyl)‐2‐(N‐Phenyl Amino)‐1,3,4‐Oxadiazole): In Vitro, In Silico, and Network Pharmacological Approaches

  2025cites this paper
• Preoperative MRI and CA19-9 for predicting occult lymph node metastasis in small pancreatic ductal adenocarcinoma (≤ 2 cm)

  2025cites this paper
• Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the machine learning-based model.

  2025cites this paper
• OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer

  2025cites this paper
• Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images

  2024cites this paper
• Exploration of immune cell heterogeneity by single‐cell RNA sequencing and identification of secretory leukocyte protease inhibitor as an oncogene in pancreatic cancer

  2024cites this paper
• Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic cancer

  2024cites this paper
• Cyfra 21.1: A Useful Tumour Marker in Pancreatic Ductal Adenocarcinoma: Cross-Sectional Study

  2024cites this paper
• CT-measured body composition radiomics predict lymph node metastasis in localized pancreatic ductal adenocarcinoma

  2023cites this paper
• Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidence.

  2022cites this paper
• Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma.

  2022cites this paper
• Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer

  2022cites this paper
• Multiparameter Magnetic Resonance Quantitative Evaluation of Pancreatic Cancer with Vascular Invasion

  2022cites this paper
• Dual-energy CT with virtual monoenergetic images and iodine maps improves tumor conspicuity in patients with pancreatic ductal adenocarcinoma

  2022cites this paper
• The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment

  2021cites this paper
• A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.

  2021cites this paper
• Distal Pancreatectomy With Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer – A Case Report and Literature Review

  2021cites this paper
• Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC.

  2020cites this paper
• Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinoma

  2020cites this paper
• MODERN APPROACHES TO X-RAY DIAGNOSTICS OF NEOPLASMS OF THE PERIAMPULAR ZONE OF DUODENUM

  2020cites this paper
• Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer

  2020cites this paper
• Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma

  2020cites this paper
• High Expression of MUC15 Is Correlated with Poor Prognosis of Pancreatic Cancer and Promotes Migration, Invasion, and Chemo-Resistance In Vitro

  2020cites this paper
• The Role of Interleukin-6 and Inflammatory Cytokines in Pancreatic Cancer-Associated Depression

  2020cites this paper
• Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma

  2020cites this paper
• Carcinoma of the Pancreas

  2020cites this paper
• Neo-adjuvant therapy for pancreatic cancer: hope for the future

  2019cites this paper
• Does sentinel node biopsy play a role in pancreatic adenocarcinoma?

  2019cites this paper
• Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.

  2019cites this paper
• Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

  2018cites this paper
• Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units.

  2018cites this paper
• Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.

  2018cites this paper
• Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer

  2018influential citation
• Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival.

  2018cites this paper
• Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

  2017cites this paper
• Staging and Determination of Resectability of Pancreatic Cancer

  2017cites this paper
• Testing Mice at Risk of Pancreatic Cancer for Altered Protein Pathways Found in Diabetes

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) MRI of pancreatic cancer for radiotherapy

  2017cites this paper
• PANCREATIC CANCER CT IMAGING: COMPARISON WITH SURGERY.

  2016cites this paper
• The lymphatic system and pancreatic cancer.

  2016cites this paper
• Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness

  2016cites this paper
• Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients

  2016cites this paper
• Pancreatic Cancer Invasion of the Lymphatic Vasculature and Contributions of the Tumor Microenvironment: Roles for E-selectin and CXCR4

  2016cites this paper
• Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis

  2016cites this paper
• Pearls and pitfalls of imaging metastatic disease from pancreatic adenocarcinoma: a systematic review.

  2015cites this paper
• Title Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer

  2015cites this paper
• Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.

  2015cites this paper
• The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma.

  2015influential citation
• Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.

  2014cites this paper
• Current controversies in the stage-specific multidisciplinary management of pancreatic cancer.

  2014cites this paper
• Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.

  2014cites this paper
• The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma

  2014cites this paper
• Neoadjuvant therapy in borderline resectable pancreatic ductal adenocarcinoma: A single institution review

  2014cites this paper
• Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

  2014cites this paper
• Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base

  2014cites this paper
• Feasibility and Safety of Intraoperative Electrochemotherapy in Locally Advanced Pancreatic Tumor: A Preliminary Experience

  2014cites this paper
• Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery

  2013cites this paper
• Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma

  2013cites this paper
• Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9

  2013cites this paper
• Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer

  2013cites this paper
• CA 19-9 tumor marker: is it reliable? A case report in a patient with pancreatic cancer.

  2013cites this paper
• Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer

  2013cites this paper
• Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma.

  2013cites this paper
• Artificial neural networks predict survival from pancreatic cancer after radical surgery.

  2013cites this paper
• Impact of omission of elective nodal irradiation on treatment outcomes in locally advanced pancreatic adenocarcinoma patients treated with definitive concurrent chemoradiotherapy.

  2012cites this paper
• Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

  2012cites this paper
• Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma

  2012cites this paper
• Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer.

  2012cites this paper
• Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

  2012cites this paper
• Pancreatic Carcinoma Cell Lines Reflect Frequency and Variability of Cancer Stem Cell Markers in Clinical Tissue

  2012cites this paper
• Low Expression of IGFBP7 is Associated with Poor Outcome of Pancreatic Ductal Adenocarcinoma

  2012cites this paper
• Pancreatic cancer: surgical management and outcomes after 6 years of follow‐up

  2012cites this paper
• PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker

  2012cites this paper
• Is celiac axis resection justified for T4 pancreatic body cancer?

  2012cites this paper
• Losses at chromosome 4q are associated with poor survival in operable ductal pancreatic adenocarcinoma.

  2012cites this paper
• Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.

  2012cites this paper
• Improved diagnostic accuracy of pancreatic diseases with a combination of various novel serum biomarkers--case control study from Manipal Teaching Hospital, Pokhara, Nepal.

  2012cites this paper
• Integrative Preoteomic Analysis of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Candidate Pancreatic Cancer Biomarkers

  2012influential citation
• Benign and Malignant Neoplasms of the Exocrine Pancreas

  2011cites this paper
• The role of circulating dendritic cells in patients with unresectable pancreatic cancer.

  2011cites this paper
• A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival

  2011cites this paper
• Title Adenosquamous Versus Adenocarcinoma of the Pancreas : A Population-Based Outcomes Analysis Permalink

  2011cites this paper
• Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis

  2011cites this paper
• Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival

  2011cites this paper
• Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: Proceed with Caution

  2011cites this paper
• Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview

  2011influential citation
• Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial

  2011cites this paper
• Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

  2011cites this paper
• A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.

  2011cites this paper
• Clinical Approach to Pancreatobiliary Disease

  2011cites this paper
• Heme oxygenase‐1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer

  2011cites this paper
• Imaging in Staging and Management of Pancreatic Ductal Adenocarcinoma

  2011cites this paper
• Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy

  2010cites this paper
• Patterns of Spread of Disease from the Pancreas

  2010cites this paper
• CT and Fusion PET-CT for Diagnosis, Staging and Follow-Up

  2010cites this paper
• Development and evaluation of bevacizumab-modified pegylated cationic liposomes using cellular and in vivo models of human pancreatic cancer

  2010cites this paper
• Protocolo de tallado, estudio e informe anatomopatológico de las piezas de duodenopancreatectomía cefálica por carcinoma de páncreas

  2010cites this paper
• [Pancreatic carcinoma presenting with invasion of the vena porta or the superior mesenteric vein: our experience and review of the literature].

  2010cites this paper
• Identification of susceptibility loci in a mouse model of KRASG12D-driven pancreatic cancer.

  2010cites this paper
• Intraoperative ultrasonography of the pancreas.

  2010cites this paper